The global biopharma industry and the rise of Indian drug multinationals: implication for Australian generics policy
This article provides a synopsis of the new dynamics of the global biopharma industry. The emergence of global generics companies with capabilities approximating those of 'big pharma' has accelerated the blurring of boundaries between the innovator and generics sectors. Biotechnology-based products form a large and growing segment of prescription drug markets and regulatory pathways for biogenerics are imminent. Indian biopharma multinationals with large-scale efficient manufacturing plants and growing R&D capabilities are now major suppliers of Active Pharmaceutical Ingredients (APIs) and generic drugs across both developed and developing countries. In response to generic competition, innovator companies employ a range of life cycle management techniques, including the launch of 'authorised generics'. The generics segment in Australia will see high growth rates in coming years but the prospect for local manufacturing is bleak. The availability of cheap generics in international markets has put pressure on Pharmaceutical Benefits Scheme (PBS) pricing arrangements, and a new policy direction was announced in November 2006. Lower generics prices will have a negative impact on some incumbent suppliers but industrial renewal policies for the medicines industry in Australia are better focused on higher value R&D activities and niche manufacturing of sophisticated products.
Year of publication: |
2007-06-01
|
---|---|
Authors: | Lofgren, Hans |
Publisher: |
BioMed Central Ltd. |
Subject: | Studies in Human Society not elsewhere classified |
Saved in:
freely available
Saved in favorites
Similar items by person
-
Scaling Up Aid Or Scaling Down : the Global Economic Crisis and Rwanda's Mdgs
Lofgren, Hans, (2009)
-
Creating and Using Fiscal Space for Accelerated Development in Liberia
Lofgren, Hans, (2013)
-
World Food Prices and Human Development : Policy Simulations for Archetype Low-Income Countries
Lofgren, Hans, (2012)
- More ...